Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
Svetlana E Nikoulina1, Dietmar Fuchs2, Phillip Moheno11SanRx Pharmaceuticals, Inc, La Jolla, CA, USA; 2Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, AustriaAbstract: Calcium pterins have been shown to be significant immunotherapeutic agents in models of breast...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-02-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Online Access: | http://www.dovepress.com/effect-of-orally-administered-dipterinyl-calcium-pentahydrate-on-oral--a9341 |
| _version_ | 1797936047425847296 |
|---|---|
| author | Fuchs D Nikoulina SE Moheno P |
| author_facet | Fuchs D Nikoulina SE Moheno P |
| author_sort | Fuchs D |
| collection | DOAJ |
| description | Svetlana E Nikoulina1, Dietmar Fuchs2, Phillip Moheno11SanRx Pharmaceuticals, Inc, La Jolla, CA, USA; 2Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, AustriaAbstract: Calcium pterins have been shown to be significant immunotherapeutic agents in models of breast cancer, hepatitis B, and tuberculosis (Bacillus Calmette-Guérin mycobacteria). These compunds modulate the immuno-enzyme indoleamine 2,3-dioxygenase (IDO) and the blood levels of several identified inflammatory cytokines. Recent research into the pathology of diabetes implicates inflammatory factors in the progression of the disease, leading the authors to study its possible control by one of the calcium pterins, dipterinyl calcium pentahydrate (DCP).The investigators tested DCP as a novel therapeutic for type 2 diabetes. Female C57BL/6 J mice with diet-induced obesity were fed a high-fat diet and were administered DCP in 0.4% carboxymethylcellulose for 21 days. Blood glucose was followed during the dosing period, and an oral glucose tolerance test (OGTT) was carried out on day 21. Measurements of plasma indoleamine 2,3-dioxygenase metabolites (tryptophan and kynurenine) and certain cytokines and chemokines were also taken. DCP 7 mg/kg/day reduced OGTT area under the curve (OGTT/AUC) by 50% (P < 0.05). A significant multivariate regression (P = 0.013; R2 = 0.571) of OGTT/AUC was derived from DCP dosage and plasma Trp. Elevated plasma Trp concentration, likely from heterogeneity in diet and/or indoleamine 2,3-dioxygenase activity, was found to correlate with higher OGTT/AUC diabetic measures, possibly via inhibition of histamine degradation. In conclusion, an optimum dose of DCP 7 mg/kg/day significantly improved the OGTT diabetic state in these female diet-induced obese mice.Keywords: diabetes, immunotherapy, oral glucose tolerance test, tryptophan, kynurenine |
| first_indexed | 2024-04-10T18:23:33Z |
| format | Article |
| id | doaj.art-8a1efcd4dc8c4f15886ee1c6458b8f7d |
| institution | Directory Open Access Journal |
| issn | 1178-7007 |
| language | English |
| last_indexed | 2024-04-10T18:23:33Z |
| publishDate | 2012-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Diabetes, Metabolic Syndrome and Obesity |
| spelling | doaj.art-8a1efcd4dc8c4f15886ee1c6458b8f7d2023-02-02T06:40:02ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072012-02-012012default4347Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese miceFuchs DNikoulina SEMoheno PSvetlana E Nikoulina1, Dietmar Fuchs2, Phillip Moheno11SanRx Pharmaceuticals, Inc, La Jolla, CA, USA; 2Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, AustriaAbstract: Calcium pterins have been shown to be significant immunotherapeutic agents in models of breast cancer, hepatitis B, and tuberculosis (Bacillus Calmette-Guérin mycobacteria). These compunds modulate the immuno-enzyme indoleamine 2,3-dioxygenase (IDO) and the blood levels of several identified inflammatory cytokines. Recent research into the pathology of diabetes implicates inflammatory factors in the progression of the disease, leading the authors to study its possible control by one of the calcium pterins, dipterinyl calcium pentahydrate (DCP).The investigators tested DCP as a novel therapeutic for type 2 diabetes. Female C57BL/6 J mice with diet-induced obesity were fed a high-fat diet and were administered DCP in 0.4% carboxymethylcellulose for 21 days. Blood glucose was followed during the dosing period, and an oral glucose tolerance test (OGTT) was carried out on day 21. Measurements of plasma indoleamine 2,3-dioxygenase metabolites (tryptophan and kynurenine) and certain cytokines and chemokines were also taken. DCP 7 mg/kg/day reduced OGTT area under the curve (OGTT/AUC) by 50% (P < 0.05). A significant multivariate regression (P = 0.013; R2 = 0.571) of OGTT/AUC was derived from DCP dosage and plasma Trp. Elevated plasma Trp concentration, likely from heterogeneity in diet and/or indoleamine 2,3-dioxygenase activity, was found to correlate with higher OGTT/AUC diabetic measures, possibly via inhibition of histamine degradation. In conclusion, an optimum dose of DCP 7 mg/kg/day significantly improved the OGTT diabetic state in these female diet-induced obese mice.Keywords: diabetes, immunotherapy, oral glucose tolerance test, tryptophan, kynureninehttp://www.dovepress.com/effect-of-orally-administered-dipterinyl-calcium-pentahydrate-on-oral--a9341 |
| spellingShingle | Fuchs D Nikoulina SE Moheno P Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice Diabetes, Metabolic Syndrome and Obesity |
| title | Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice |
| title_full | Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice |
| title_fullStr | Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice |
| title_full_unstemmed | Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice |
| title_short | Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice |
| title_sort | effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet induced obese mice |
| url | http://www.dovepress.com/effect-of-orally-administered-dipterinyl-calcium-pentahydrate-on-oral--a9341 |
| work_keys_str_mv | AT fuchsd effectoforallyadministereddipterinylcalciumpentahydrateonoralglucosetoleranceindietinducedobesemice AT nikoulinase effectoforallyadministereddipterinylcalciumpentahydrateonoralglucosetoleranceindietinducedobesemice AT mohenop effectoforallyadministereddipterinylcalciumpentahydrateonoralglucosetoleranceindietinducedobesemice |